Dr. Sam Michael Faradyan, MD

Dr. Faradyan practices at The Cleveland Clinic Florida - HOPD in West Palm Beach, Florida.

Dr. Faradyan's NPI, 1013076470, was assigned on December 8, 2006. Dr. Faradyan graduated from George Washington University School of Medicine and Health Sciences in 2002. Dr. Faradyan holds Florida license 109689.

Dr. Faradyan's primary practice is The Cleveland Clinic Florida - HOPD, at 525 Okeechobee Blvd, West Palm Beach, FL 33401.

Dr. Faradyan's primary practice is The Cleveland Clinic Florida - HOPD in West Palm Beach, Florida. Dr. Faradyan is also affiliated with Good Samaritan Medical Center. The medical group on file is Cleveland Clinic Florida. Dmand AI also links Dr. Faradyan to 3 more hospitals and 1 group practice or clinic, each named with a free account. Dr. Faradyan's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Faradyan practices, 6 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Faradyan's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Faradyan is board certified in critical care medicine by the American Board of Internal Medicine. Dmand AI has Dr. Faradyan's licenses on file in 3 states: Florida, New York and Rhode Island.

Dmand AI lists asthma, bronchitis, chronic lung disease, chronic obstructive pulmonary disease (COPD), chronic respiratory failure, pleural effusion, pulmonary fibrosis and pulmonary heart disease among the conditions Dr. Faradyan treats.

CMS data shows 1,774 Medicare services from Dr. Faradyan across 18 procedure codes in 2024, for 637 Medicare patients. Medicare paid $114,830 for them.

CMS counts 637 Medicare patients who saw Dr. Faradyan in 2024. The largest group is 65 to 74, with 263 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.86, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Faradyan's median patient age at 69, with 56% women.

In 2024, Dr. Faradyan wrote 2,806 Medicare Part D claims for 462 patients. CMS names the drug for 2,617 of them, across 40 drugs with 11 or more claims each, at $1,634,200 in total drug cost. In 2023, CMS named 2,597 claims across 40 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Dr. Faradyan for performance year 2024, reported through an alternative payment model (APM). Dr. Faradyan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Faradyan as offering telehealth.

Dmand AI links 1 paper to Dr. Faradyan in 2012. Dr. Faradyan's most frequent co-authors are Jason M. Aliotta, MD and Laura Goldberg, MD, PhD.

CMS Open Payments shows 110 general payments to Dr. Faradyan from 15 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $1,059.

Dmand AI lists 1 award for Dr. Faradyan, most recently CMS Stage 1 EHR in 2013.

Dr. Faradyan graduated from George Washington University School of Medicine and Health Sciences in 2002.

Dr. Faradyan is in network with 16 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.